Drug
VX 581
VX 581: highest development phase Phase 1, developed by Vertex Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VX-581 NCT07283770 | Phase 1 | Cystic Fibrosis |
| VX-581 NCT07813039 | Phase 1 | Cystic Fibrosis |
Latest
No recent events.
Follow VX 581 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.